OncoDaily Senior Vice President Shushan Hovsepyan Named Candidate for UICC Board of Directors 2026–2028
WHO Unveils 2026–2030 Strategy to Close the Childhood Cancer Medicines Gap
Japan Approves Enhertu Plus Pertuzumab and Datroway in Two New First-Line Metastatic Breast Cancer Settings
FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer
The Big Questions in Cancer Immunotherapy: Why Do “Cold” Tumors Stay Invisible to the Immune System?
ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC
Muna Al-Khaifi: Understanding Cognitive Changes After Cancer
HRH Princess Dina Mired: In Memoriam of My Dear Friend Navid Madani
